What is Cassava Sciences Inc?
, a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 142.03M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.